Research to the People @ Stanford's 2023 oncology cases will launch soon.
Personalis ImmunoID Next:
The unique design of ImmunoID NeXT and our analytical algorithms enables you to interrogate critical tumor- and immune-related information including:
- Immunocellular profile within tumor microenvironment
- T-cell and B-cell receptor (TCR/BCR) repertoire
- Neoantigen prediction with SHERPA
- NEOPS (Personalis Composite Neoantigen Presentation Score) biomarker
- Tumor mutational burden (TMB)
- Microsatellite instability (MSI) characterization
- Human leukocyte antigens (HLA) typing, HLA and beta-2 microglobulin (B2M) somatic mutations, and HLA loss of heterozygosity (LOH)
- Oncoviral detection
Teiko.Bio Toku Profile
Deep immune profiling enables more complete understanding and informed decision making. TokuProfile identifies:
- Abundance of different immune cell types
- Activation scores for each immune cell type
- Rational targets for suggested combination
- Immune features associated with response
Learn More at Teiko.Bio